Itay Shafat

1.3k total citations
27 papers, 1.1k citations indexed

About

Itay Shafat is a scholar working on Cell Biology, Molecular Biology and Hematology. According to data from OpenAlex, Itay Shafat has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cell Biology, 21 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Itay Shafat's work include Proteoglycans and glycosaminoglycans research (21 papers), Glycosylation and Glycoproteins Research (14 papers) and Fibroblast Growth Factor Research (9 papers). Itay Shafat is often cited by papers focused on Proteoglycans and glycosaminoglycans research (21 papers), Glycosylation and Glycoproteins Research (14 papers) and Fibroblast Growth Factor Research (9 papers). Itay Shafat collaborates with scholars based in Israel, United States and Switzerland. Itay Shafat's co-authors include Israël Vlodavsky, Neta Ilan, Yona Nadir, Benjamin Brenner, Eyal Zcharia, Farid Nakhoul, Gil Arvatz, Rafael M. Nagler, Flonia Levy‐Adam and Oded Hershkovich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Itay Shafat

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itay Shafat Israel 21 733 647 223 150 118 27 1.1k
Elspeth Payne United Kingdom 15 269 0.4× 542 0.8× 384 1.7× 80 0.5× 96 0.8× 37 1.2k
Tina M. Misenheimer United States 16 167 0.2× 648 1.0× 112 0.5× 277 1.8× 56 0.5× 23 954
Benjamin Richard France 17 124 0.2× 257 0.4× 317 1.4× 279 1.9× 100 0.8× 26 873
Kane L. Schaphorst United States 16 289 0.4× 753 1.2× 115 0.5× 128 0.9× 50 0.4× 18 1.1k
Christopher M. Spring Canada 15 109 0.1× 468 0.7× 392 1.8× 57 0.4× 86 0.7× 22 1.0k
Maria Kauppi Australia 16 273 0.4× 438 0.7× 273 1.2× 45 0.3× 88 0.7× 21 852
Sebastian Dütting Germany 12 98 0.1× 256 0.4× 360 1.6× 74 0.5× 75 0.6× 18 846
Véronique Arocas France 18 107 0.1× 249 0.4× 474 2.1× 314 2.1× 79 0.7× 35 880
Andrea Farina Italy 18 134 0.2× 1.1k 1.8× 111 0.5× 136 0.9× 107 0.9× 35 1.5k
Satoshi Yamaji Japan 17 276 0.4× 534 0.8× 94 0.4× 124 0.8× 45 0.4× 41 1.1k

Countries citing papers authored by Itay Shafat

Since Specialization
Citations

This map shows the geographic impact of Itay Shafat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itay Shafat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itay Shafat more than expected).

Fields of papers citing papers by Itay Shafat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itay Shafat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itay Shafat. The network helps show where Itay Shafat may publish in the future.

Co-authorship network of co-authors of Itay Shafat

This figure shows the co-authorship network connecting the top 25 collaborators of Itay Shafat. A scholar is included among the top collaborators of Itay Shafat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itay Shafat. Itay Shafat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nissan, Israel, Salit Tzaban, Albert Taraboulos, et al.. (2015). Transgenic over-expression of mammalian heparanase delays prion disease onset and progression. Biochemical and Biophysical Research Communications. 464(3). 698–704. 5 indexed citations
2.
Nadir, Yona, Galit Sarig, Alona Meir, et al.. (2014). Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients. Thrombosis Research. 134(3). 639–642. 24 indexed citations
3.
Shafat, Itay, Mona Boaz, Doron Schwartz, et al.. (2012). Elevated Urine Heparanase Levels Are Associated with Proteinuria and Decreased Renal Allograft Function. PLoS ONE. 7(9). e44076–e44076. 29 indexed citations
4.
Shafat, Itay, et al.. (2011). Heparanase Levels Are Elevated in the Urine and Plasma of Type 2 Diabetes Patients and Associate with Blood Glucose Levels. PLoS ONE. 6(2). e17312–e17312. 87 indexed citations
5.
Arvatz, Gil, Itay Shafat, Flonia Levy‐Adam, Neta Ilan, & Israël Vlodavsky. (2011). The heparanase system and tumor metastasis: is heparanase the seed and soil?. Cancer and Metastasis Reviews. 30(2). 253–268. 85 indexed citations
6.
Nadir, Yona, et al.. (2011). An assay to evaluate heparanase procoagulant activity. Thrombosis Research. 128(4). e3–e8. 24 indexed citations
7.
Shafat, Itay, Josephine Issakov, Isaac Meller, et al.. (2010). Pre-clinical and clinical significance of heparanase in Ewing’s sarcoma. Journal of Cellular and Molecular Medicine. 15(9). 1857–1864. 46 indexed citations
8.
Nadir, Yona, et al.. (2010). Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII. Haematologica. 95(11). 1927–1934. 70 indexed citations
9.
Nasser, Nicola J., Aaron Avivi, Itay Shafat, et al.. (2009). Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis. Proceedings of the National Academy of Sciences. 106(7). 2253–2258. 46 indexed citations
10.
Arush, Myriam Weyl Ben, et al.. (2009). PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study. Pediatric Hematology and Oncology. 26(4). 157–164. 13 indexed citations
11.
Shafat, Itay, Dov Pode, Tamar Peretz, et al.. (2008). Clinical Significance of Urine Heparanase in Bladder Cancer Progression. Neoplasia. 10(2). 125–130. 31 indexed citations
12.
Vlodavsky, Israël, et al.. (2008). Heparanase: One Molecule with Multiple Functions in Cancer Progression. Connective Tissue Research. 49(3-4). 207–210. 77 indexed citations
13.
Nagler, Rafael M., Ofer Ben‐Izhak, Victoria Cohen‐Kaplan, et al.. (2007). Heparanase up‐regulation in tongue cancer. Cancer. 110(12). 2732–2739. 21 indexed citations
14.
Shafat, Itay, Sergey Postovsky, Ronit Elhasid, et al.. (2007). Heparanase Levels Are Elevated in the Plasma of Pediatric Cancer Patients and Correlate with Response to Anticancer Treatment. Neoplasia. 9(11). 909–916. 34 indexed citations
15.
Hershkovich, Oded, Itay Shafat, & Rafael M. Nagler. (2007). Age-Related Changes in Salivary Antioxidant Profile: Possible Implications for Oral Cancer. The Journals of Gerontology Series A. 62(4). 361–366. 48 indexed citations
16.
Shafat, Itay, Svetlana Gingis‐Velitski, Yehudit Amor, et al.. (2007). Low and high affinity receptors mediate cellular uptake of heparanase. The International Journal of Biochemistry & Cell Biology. 40(3). 530–542. 25 indexed citations
17.
Shafat, Itay, Israël Vlodavsky, & Neta Ilan. (2006). Characterization of Mechanisms Involved in Secretion of Active Heparanase. Journal of Biological Chemistry. 281(33). 23804–23811. 62 indexed citations
18.
Shafat, Itay, Eyal Zcharia, Benjamin Nisman, et al.. (2006). An ELISA method for the detection and quantification of human heparanase. Biochemical and Biophysical Research Communications. 341(4). 958–963. 73 indexed citations
19.
Nasser, Nicola J., Eviatar Nevo, Itay Shafat, et al.. (2005). Adaptive evolution of heparanase in hypoxia-tolerantSpalax: Gene cloning and identification of a unique splice variant. Proceedings of the National Academy of Sciences. 102(42). 15161–15166. 30 indexed citations
20.
Adir, Noam, E. Dobrovetsky, Itay Shafat, Cyril J. Cohen, & Yechezkel Kashi. (2002). Isolation, purification and preliminary X-ray characterization of Cpn60-2 (65 kDa heat-shock protein) fromMycobacterium tuberculosis. Acta Crystallographica Section D Biological Crystallography. 58(9). 1474–1475. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elspeth Payne Breakdown of academic impact, for papers by Tina M. Misenheimer Breakdown of academic impact, for papers by Benjamin Richard Breakdown of academic impact, for papers by Kane L. Schaphorst Breakdown of academic impact, for papers by Christopher M. Spring Breakdown of academic impact, for papers by Maria Kauppi Breakdown of academic impact, for papers by Sebastian Dütting Breakdown of academic impact, for papers by Véronique Arocas Breakdown of academic impact, for papers by Andrea Farina Breakdown of academic impact, for papers by Satoshi Yamaji
Rankless by CCL
2026